logo
Products
Technologies
Applications
Services
Resources
Selection Guides
About
iFluor® 568 Anti-human CD3 Antibody
SK7
The SK7 monoclonal antibody reacts with human CD3e, a 20 kD member of the Ig superfamily often found on the surface of t cells, tregs and nkt cells. In many organisms, CD3 positively regulates interleukin-2 biosynthetic process, enhances cell-matrix adhesion and is a positive regulator of gene expression. Moreover, it plays a role in essential cellular pathways, for example, the T cell receptor signaling pathway, negative regulation of smoothened signaling pathway and apoptotic signaling pathway. From a research standpoint, it is of biological interest due to its association with vital macromolecules/ligands like TCR. CD3 is a very popular antibody target, with over 80000 publications in the last decade. CD3e is frequently used in flow cytometry applications as a phenotypic marker for differentiation of cell types, particularly in the study of immunology. This antibody was purified through affinity chromatography and conjugated to iFluor® 568 (ex/em = 568/587 nm). It is compatible with the 561 nm laser and 586/14 nm bandpass filter (for example, as in the BD LSRFortessa™ X-20).
product image
product image
CatalogSize
Price
Quantity
100330B0100 tests
Price
100330B1500 tests
Price
 
Antibody properties

Other namesT3E
CloneSK7
HostMouse
ReactivityHuman
ApplicationFlow Cytometry (FACS), Fluorescence Imaging
Spectral properties

Correction factor (260 nm)0.34
Correction factor (280 nm)0.15
Extinction coefficient (cm -1 M -1)
100000
1
Excitation (nm)568
Emission (nm)587
Quantum yield
0.57
1
Storage, safety and handling

H-phraseH303, H313, H333
Hazard symbolXN
Intended useResearch Use Only (RUO)
R-phraseR20, R21, R22
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on December 10, 2025